Serotonin laterality in amygdala predicts performance in the elevated plus maze in rats

NeuroReport

Volumn 10, Issue 17, 1999, Pages 3497-3500

  Andersen, Susan L ^a   Teicher, Martin H ^a  

^a MCLEAN HOSPITAL   (United States)

Author keywords

Attention; Dopamine; Emotion; Hemisphere; Laterality

Indexed keywords

DOPAMINE; SEROTONIN;

ADOLESCENT; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; ATTENTION; BRAIN ASYMMETRY; CONTROLLED STUDY; EMOTION; FEMALE; MALE; MAZE TEST; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

EID: 0033607437     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199911260-00006     Document Type: Article

References (22)

1. 1. Teicher M. Med Clin N Am 72, 791-814 (1988).
2. 2. LeDoux J. Prog Brain Res 107, 437-446 (1996).
3. 3. Joseph R. J Clin Psychol 44, 630-673 (1988).
4. 4. Schiffer F. Harv Rev Psychiatry 4, 126-138 (1996).
5. 5. Rauch SL, van der Kolk BA, Fisler RE et al. Arch Gen Psychiatry 53, 380-387 (1996).
6. 6. Deakin JF. Int Clin Psychophamacol 6 (Suppl. 3), 23-28; discussion 29-31 (1991).
7. 7. Arato M, Frecska E, Tekes K and MacCrimmon DJ. Acta Psychiatr Scand 84, 110-111 (1991).
8. 8. Belcheva I, Belcheva S, Petkov VV and Petkov VD. Neuropharmacology 33, 995-1002 (1994).
9. 9. Belcheva I, Belcheva S, Petkov VV and Petkov VD. Brain Res 640, 223-228 (1994).
10. 10. Schwarting RK, Thiel CM, Muller CP and Huston JP. Neuroreport 9, 1025-1029 (1998).
11. 11. Andersen S, Dumont M and Teicher M. Early Postnatal Clomipramine Treatment as an Animal Model of Depression. New Orleans, LA: Society for Neuroscience, 1997.
12. 12. Mirmiran M, van de Poll NE, Corner MA et al. Brain Res 204, 129-146 (1981).
13. 13. Dawson GR and Tricklebank MD. Trends Pharmacol Sci 16, 33-36 (1995).
14. 14. File SE and Johnston AL. Psychopharmacology 99, 248-251 (1989).
15. 15. Costall B and Naylor RJ. Pharmacol Toxicol 70, 157-162 (1992).
16. 16. Costall B, Domeney AM, Kelly ME et al. Eur J Pharmacol 234, 91-99 (1993).
17. 17. Rocha B, Rigo M, Di Scala G et al. Eur J Pharmacol 262, 125-131 (1994).
18. 18. Deckel AW and Fuqua L. Behav Brain Res 95, 227-232 (1998).
19. 19. Graeff FG, Guimaraes FS, De Andrade TG and Deakin JF. Pharmacol Biochem Behav 54, 129-141 (1996).
20. 20. File SE and Gonzalez LE. Pharmacol Biochem Behav 54, 123-128 (1996).
21. 21. Casey BJ, Castellanos FX, Giedd JN et al. J Am Acad Child Adolesc Psychiatry 36, 374-383 (1997).
22. 22. Epstein JN, Conners CK, Erhardt D et al. Neuropsychology 11, 467-473 (1997).